Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: Its implications in the immunodeficient state

Blood

Volumn 97, Issue 10, 2001, Pages 3177-3183

  Yasunaga, Jun Ichirou ^a,b,c   Sakai, Tatsunori ^a,b,c   Nosaka, Kisato ^a,b,c   Etoh, Ken Ichiro ^a,b,c   Tamiya, Sadahiro ^a,b,c   Koga, Shin ^a,b,c   Mita, Shuji ^a,b,c   Uchino, Makoto ^a,b,c   Mitsuya, Hiroaki ^a,b,c   Matsuoka, Masao ^a,b,c,d  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b Amakusa Chuo General Hospital   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA RECOMBINATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE DEFICIENCY; LYMPHOCYTOPOIESIS; LYMPHOPOIESIS; MEMORY CELL; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SPASTIC PARAPLEGIA; T CELL LEUKEMIA; T LYMPHOCYTE SUBPOPULATION; THYMUS FUNCTION; VIRUS LOAD;

EID: 0035874507     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.10.3177     Document Type: Article

References (40)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77: 7415-7419.
2. Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A. 1981;78:6476-6480.
3. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A. 1982;79:2031-2035.
4. Wong-Staal F, Gallo RC. Human T-lymphotropic retroviruses. Nature. 1985;317:395-403.
5. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985;ii:407-410.
6. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986;i:1031-1032.
7. LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet. 1990;336:1345-1347.
8. Mochizuki M, Watanabe T, Yamaguchi K, et al. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res. 1992;83:236-239.
9. Takatsuki K, Uchiyama T, Sagawa K, Yodoi J. Adult T cell leukemia in Japan. In: Seno S, Takaku F, Irino S, eds. Topics in Hematology. Proceedings of the 16th International Congress of Hematology. Amsterdam, The Netherlands. Excerpta Medica. 1977;73-77.
10. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481-492.
11. Takatsuki K, Yamaguchi K, Matsuoka M. ATL and HTLV-I-related diseases. In: Takatsuki K, ed. Adult T-Cell Leukemia. New York: Oxford University Press; 1994:1-27.
12. Greenberg SJ, Jaffe ES, Ehrlich GD, Korman NJ, Poiesz BJ, Waldmann TA. Kaposi's sarcoma in human T-cell leukemia virus type I-associated adult T cell leukemia. Blood. 1990;76:971-976.
13. Tobinai K, Ohtsu T, Hayashi M, et al. Epstein-Barr virus (EBV) genome carrying monoclonal B-cell lymphoma in a patient with adult T-cell leukemialymphoma. Leuk Res. 1991;15:837-846.
14. Katsuki T, Katsuki K, Imai J, Hinuma Y. Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-I): impairment of T-cell control of Epstein-Barr virus-infected B-cells. Jpn J Cancer Res. 1987;78:639-642.
15. Sadahira Y, Nishihara H, Shimizu M, et al. Epstein-Barr virus-associated Hodgkin's disease in HTLV-I seropositive patients: a report of two cases. Pathol Int. 1998;48:67-73.
16. Tachibana N, Okayama A, Ishizaki J, et al. Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan. Int J Cancer. 1988;42:829-831.
17. Welles SL, Tachibana N, Okayama A, et al. Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status. Int J Cancer, 1994;56:337-340.
18. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA, Herzenberg LA. CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest. 1995;95:2061-2066.
19. + T cells provides new insights on immunodeficiency in aging. Blood. 2000;95:2860-2868.
20. Sempowski GD, Hale LP, Sundy JS, et al. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J Immunol. 2000;164:2180-2187.
21. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection, Nature. 1998;396: 690-695.
22. Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG. In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol. 1990;64:5682-5687.
23. Worner I, Matutes E, Beverley PC, Catovsky D. The distribution of CD45R, CD29 and CD45RO (UCHL1) antigens in mature CD4 positive T-cell leukaemias. Br J Haematol. 1990;74:439-444.
24. Yoshida M, Osame M, Kawai H, et al. Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann Neurol. 1989;26:331-335.
25. Etoh K, Yamaguchi K, Tokudome S, et al. Rapid quantification of HTLV-I provirus load: detection of monoclonal proliferation of HTLV-I-infected cells among blood donors. Int J Cancer. 1999;81:859-864.
26. Zhang L, Lewin SR, Markowitz M, et al. Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J Exp Med. 1999;190:725-732.
27. Weiss RA. Viruses, cancer and AIDS. FEMS Immunol Med Microbiol. 1999;26:227-232.
28. Okano M, Gross TG. A review of Epstein-Barr virus infection in patients with immunodeficiency disorders. Am J Med Sci. 2000;319:392-396.
29. Tokunaga M, Imai S, Uemura Y, Tokudome T, Osato T, Sato E. Epstein-Barr virus in adult T-cell leukemia/lymphoma. Am J Pathol. 1993;143:1263-1268.
30. Akashi K, Kondo M, Weissman IL. Role of interleukin-7 in T-cell development from hematopoietic stem cells. Immunol Rev. 1998;165:13-28.
31. Simpson RM, Zhao TM, Hubbard BS, Sawasdikosol S, Kindt TJ. Experimental acute adult T cell leukemia-lymphoma is associated with thymic atrophy in human T cell leukemia virus type I infection. Lab Invest. 1996;74:696-710.
32. Furuta Y, Aizawa S, Suda Y, et al. Thymic atrophy characteristic in transgenic mice that harbor pX genes of human T-cell leukemia virus type I. J Virol. 1989;63:3185-3189.
33. Nishimoto N, Yoshizaki K, Eiraku N, et al. Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Neurol Sci. 1990;97:183-193.
34. Kuroda Y, Takashima H. Impairment of cell-mediated immune responses in HTLV-I-associated myelopathy. J Neurol Sci. 1990;100:211-216.
35. Welles SL, Tachibana N, Okayama A, et al. Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status. Int J Cancer. 1994;56:337-340.
36. Matsuyama W, Mizoguchi A, Iwami F, et al. Clinical investigation of pulmonary Mycobacterium avium complex infection in human T lymphotrophic virus type I carriers. Thorax. 2000;55:388-392.
37. D'Souza MP, Fauci AS. Immunopathogenesis. In: Merigan TC, Bartlett JG, Bolobnesi D, eds. AIDS Medicine. Baltimore: Williams & Wilkins; 1999:59-85.
38. Etoh K, Tamiya S, Yamaguchi K, et al. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res. 1997;57:4862-4867.
39. Cavrois M, Leclercq I, Gout O, et al. Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with tropical spastic paraparesis/HTLV-1 associated myelopathy. Oncogene. 1998;17:77-82.
40. Koyanagi Y, Itoyama Y, Nakamura N, et al. In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology. 1993;196:25-33.